News in the Life Sciences Industry | |
Results 161 - 180 out of 500 displayed. | |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » |
Sedana Medical submits market approval application for the drug Sedaconda |
STOCKHOLM, Nov. 27, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for market approval for the drug candidate Sedaconda (isoflurane), formerly known as IsoConDa, for inhaled sedation in intensive care. The... Read more ›› |
By: PR Newswire Association LLC. - 27 Nov 2020 |
Related companies: Sedana Medical AB (publ) |
Calliditas Therapeutics' nomination committee for the AGM 2021 |
STOCKHOLM, Nov. 27, 2020 /PRNewswire/ -- Calliditas Therapeutics AB (publ.) publishes the nomination committee's composition for the AGM in 2021. Read more ›› |
By: PR Newswire Association LLC. - 27 Nov 2020 |
Related companies: Calliditas Therapeutics AB |
Sectra's six-month interim report 2020/2021: Increase in profit and order bookings, but deliveries impacted by pandemic restrictions |
LINKÖPING, Sweden, Nov. 27, 2020 /PRNewswire/ -- Demand for the international medical imaging IT and cybersecurity company Sectra's... Read more ›› |
By: PR Newswire Association LLC. - 27 Nov 2020 |
Related companies: Sectra AB |
BioInvent strengthens Investor Relations |
LUND, Sweden, Nov. 27, 2020 /PRNewswire/ -- BioInvent International AB ("BioInvent") (OMXS: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, announced today the appointment of Cecilia Hofvander... Read more ›› |
By: PR Newswire Association LLC. - 27 Nov 2020 |
Related companies: BioInvent International AB |
Resolutions at the Extraordinary General Meeting in BioInvent on November 27, 2020 |
LUND, Sweden, Nov. 27, 2020 /PRNewswire/ -- BioInvent International AB's (publ) ("BioInvent") (OMXS: BINV) Extraordinary General Meeting (the "EGM") today resolved to approve the Board of Directors' resolution on a directed issue of 29,395,311 new shares and 14,697,655 new warrants... Read more ›› |
By: PR Newswire Association LLC. - 27 Nov 2020 |
Related companies: BioInvent International AB |
FDA identifies exclusive code for the CADScor® |
Read more ›› |
By: GlobenewsWire - 26 Nov 2020 |
Related companies: Acarix AB |
Gustaf Salford appointed Elekta CEO by Board of Directors |
STOCKHOLM, Nov. 26, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that Gustaf Salford has been appointed to the role of President and CEO, effective immediately. He has been Acting CEO since early June 2020. Read more ›› |
By: PR Newswire Association LLC. - 26 Nov 2020 |
Related companies: Elekta AB |
Interim report, May-October 2020/21 |
STOCKHOLM, Nov. 26, 2020 /PRNewswire/ -- In Elekta's second quarter, we managed to perform better than the overall radiotherapy market both in terms of orders and revenue despite continuous challenging circumstances. We also improved margins and stabilized cash flow. The launch of our new... Read more ›› |
By: PR Newswire Association LLC. - 26 Nov 2020 |
Related companies: Elekta AB |
IRRAS Announces Expansion of IRRAflow Launch to The Netherlands |
STOCKHOLM, Nov. 26, 2020 /PRNewswire/ -- IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced an exclusive distribution agreement with KM Innovations BV, a leading distributor of world-class neurosurgical... Read more ›› |
By: PR Newswire Association LLC. - 26 Nov 2020 |
Related companies: IRRAS AB |
BioInvent and Cantargia sign manufacturing agreement for monoclonal antibody CAN10 |
LUND, Sweden, Nov. 26, 2020 /PRNewswire/ -- Cantargia AB (OMXS: CANTA) and BioInvent International AB (OMXS: BINV), today announced that BioInvent has been contracted as manufacturer of Cantargia's antibody CAN10 in preclinical development for the treatment of systemic sclerosis and myocarditis.... Read more ›› |
By: PR Newswire Association LLC. - 26 Nov 2020 |
Related companies: BioInvent International AB |
InDex Pharmaceuticals to host virtual R&D day on December 8, 2020 |
STOCKHOLM, Nov. 26, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) ("InDex") today announced that the company will host a virtual R&D day on Tuesday December 8, 2020 for investors, analysts and media. Read more ›› |
By: PR Newswire Association LLC. - 26 Nov 2020 |
Related companies: InDex Pharmaceuticals Holding AB |
Acarix receives US market approval for the CADScor® System |
Read more ›› |
By: GlobenewsWire - 25 Nov 2020 |
Related companies: Acarix AB |
Active Biotech announces the final terms of the rights issue |
Read more ›› |
By: GlobenewsWire - 25 Nov 2020 |
Related companies: Active Biotech AB |
RhoVac's Prostate Cancer Drug Candidate, RV001, is granted Fast Track Designation by the FDA |
LUND, Sweden, Nov. 25, 2020 /PRNewswire/ -- RhoVac, a clinical stage company today announced that the American FDA has granted Fast Track Designation to the company's drug candidate, RV001. Fast Track Designation is granted to investigational drugs for expedited review by the FDA, to facilitate... Read more ›› |
By: PR Newswire Association LLC. - 25 Nov 2020 |
Related companies: RhoVac AB |
Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Awardees of the Seoul Innovation QuickFire Challenge on Healthcare for the New Normal in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute |
SEOUL, South Korea, Nov. 24, 2020 /PRNewswire/ -- Janssen Korea Ltd. and Johnson & Johnson Innovation LLC today, in collaboration with the Seoul Metropolitan Government (SMG) and Korea Health Industry Development Institute (KHIDI), named DC Medical and deepmedi as awardees of the Read more ›› |
By: PR Newswire Association LLC. - 25 Nov 2020 |
Program for Oncopeptides virtual Capital Markets Day on November 30 is published |
STOCKHOLM, Nov. 24, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, today announces that the company has finalized the program for the upcoming... Read more ›› |
By: PR Newswire Association LLC. - 24 Nov 2020 |
Related companies: Oncopeptides AB |
ACTIVE BIOTECH UPDATES ITS CLINICAL STRATEGY AND PROJECTED MILESTONES |
Read more ›› |
By: GlobenewsWire - 24 Nov 2020 |
Related companies: Active Biotech AB |
Correction to previous pressrelease: Active Biotech updates its clinical strategy and projected milestones |
Read more ›› |
By: GlobenewsWire - 24 Nov 2020 |
Related companies: Active Biotech AB |
Sanofi: Disclosure of trading in own shares |
Read more ›› |
By: GlobenewsWire - 23 Nov 2020 |
Novo Nordisk A/S – Share repurchase programme |
Read more ›› |
By: GlobenewsWire - 23 Nov 2020 |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » |
Upcoming Life Sciences Events
- January 2021
- BioSeed Digital 2021
- NutrEvent
- AgeingFIT
Latest company news
Doptelet® (avatrombopag) approved in the EU for treatment of ITP